Company intelligence
BIOTYPE GmbH
Detect more. Decide better.
About BIOTYPE GmbH
BIOTYPE is an innovative German solution provider for molecular precision diagnostics. We are committed to advancing precision medicine through our products & services for reliable analysis and interpretation of clinical biomarkers. BIOTYPE offers a strong portfolio in molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio includes IVD assays for clinical diagnostics and RUO assays for translational and clinical research. In addition, BIOTYPE offers high-quality and IVD-compliant contract development and manufacturing services. Our proprietary MODAPLEX platform is a benchtop system for automated molecular profiling and multi-biomarker testing. MODAPLEX addresses the growing need to simplify and accelerate precision testing by reliably delivering actionable molecular information required for biomarker-guided care in precision medicine. The MODAPLEX consolidates multi-gene testing into one workflow with same-day results. BIOTYPE‘s quality management system is certified according to ISO 9001:2015 & ISO 13485:2016.
Verified activity
Signals from BIOTYPE GmbH
2 published signals
Presence & Recognition
BIOTYPE GmbH is attending the 38th European Congress of Pathology in Stockholm from 12th to 16th September 2026 at Booth 321 in Hall B.
Reported by BIOTYPE GmbH
Products & Services
BIOTYPE GmbH expanded its hemato-oncology portfolio with Mentype AMLplus and Mentype AMLplexQS to offer a comprehensive solution for detecting AML-associated mutations and gene fusions.
Reported by BIOTYPE GmbH